Package 42291-821-10

Brand: terazosin

Generic: terazosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42291-821-10
Digits Only 4229182110
Product NDC 42291-821
Product ID 42291-821_3a9ec205-cdb5-e131-e063-6294a90acb60
Description

1000 CAPSULE in 1 BOTTLE (42291-821-10)

Marketing

Marketing Status
Marketed Since 2020-03-30
Brand terazosin
Generic terazosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Terazosin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a9ec205-cdb5-e131-e063-6294a90acb60", "openfda": {"upc": ["0342291823105", "0342291820104", "0342291821101"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["a2137488-8554-e84f-e053-2995a90a796c"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (42291-821-10)", "package_ndc": "42291-821-10", "marketing_start_date": "20200330"}], "brand_name": "Terazosin", "product_id": "42291-821_3a9ec205-cdb5-e131-e063-6294a90acb60", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "42291-821", "generic_name": "Terazosin Hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20200330", "listing_expiration_date": "20261231"}